In 2008, when we first envisaged a professional journal dedicated to pulmonary vascular disease, it was our hope that others in our field would share our conviction that such a journal was needed. The response to our inaugural issue, published this past March, has vindicated that hope beyond expectation. From colleagues, trainees and students we received feedback, including suggestions for improvement, many of which we are incorporating. For example, we are premiering a new feature in this issue, at the foot of this page–corrections or clarifications of points in previous issues either by authors (Corrigenda) or by the editors (Errata). This issue also premieres an exciting new type of contribution, the Snapshot. Each of these will be a single page compilation on a particular topic. This issue's Snapshot is on drugs for pulmonary hypertension.